Increases in PAI1 concentration have been positively associated with risk for CVD, ischemic heart disease and stroke, with metabolic abnormalities such as diabetes and metabolic syndrome, and increased inflammation [45, 72]. The gene discussed is SERPINE1; the disease is metabolic syndrome.